Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

MYOS RENS Technology Inc.

TRADE

NASDAQ: MYOSHealthcare / Drugs - Generic / USA
1.26-0.04-3.08%Vol 7 9731Y Perf -10.00%
Sep 25th, 2018 16:00
BID1.26 ASK1.27
Open1.27 Previous Close1.30
Pre-Market- After-Trading-
 - -%  - -%
Target Price
3.50 
Analyst Rating
— 0.00
Potencial %
177.78 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/100/100 
Income Ranking
 —    -
Market Cap (mil)8 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
15.65 
Earnings Date
13th Nov 2018

Today's Price Range

1.251.29

 

52wk Range

1.032.50

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-4.55%
3 Months
-13.10%
6 Months
-1.56%
1 Year
-10.00%
3 Years
-53.33%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
MYOS1.26-0.0400-3.08
AAPL222.191.40000.63
GOOG1 184.6511.28000.96
MSFT114.45-0.2200-0.19
XOM86.50-0.1000-0.12
WFC54.23-0.0300-0.06
JNJ138.64-1.8300-1.30
FB164.91-0.5000-0.30
GE11.27-0.4700-4.00
JPM116.39-0.3300-0.28
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 1.20
Current Ratio 5.70
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -2 096.00
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin51.90
EBIT Margin-881.20
EBITDA Margin-809.30
Pre-tax Profit Margin-1 115.10
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 2.51
PS Ratios 20.22
Price to Cash Flow -
Price to Free Cash Flow -3.10
Cash Flow Per Share -0.47
Price to Tangible Book4.19
Book Value per Share0.50
Enterprise Value (in ths.)8 834
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-93.80
ROE last 12 Months -91.27
Return on Assets (5Y Avg) -92.36
ROA last 12 Months -84.14
Return on Capital (5Y Avg) -90.12
ROC last 12 Months -92.47
Return on invested Capital Q -28.37
Return on invested Capital Y-83.78
Assets Turnover0.10
Receivables Turnover82.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)462
Revenue per Share 0.06
Revenue Growth 3 Years 39.66
Revenue Growth 5 Years -33.71
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.08-0.14-75.00
Q01 2018-0.08-0.19-137.50
Q02 2016--0.30-
Q01 2016--0.31-
Q01 2015--0.50-
Q03 2014-0.24-0.73-204.17
Q02 2014-0.20-0.32-60.00
----
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.14-75.00Negative
12/2018 QR-0.14-100.00Negative
12/2018 FY-0.60-71.43Negative
12/2019 FY-0.58-48.72Negative
Next Report Date13th Nov 2018
Estimated EPS Next Report-0.14
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume7 973
Shares Outstanding (in ths.)6 660
Trades Count16
Dollar Volume8 642
Avg. Volume134 669
Avg. Weekly Volume11 475
Avg. Monthly Volume10 749
Avg. Quarterly Volume215 498

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

80%20%

Bearish Bullish

61%39%

Bearish Bullish

53%47%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Strong Buy
1.00

There are no comments yet.

News

x